|
|
|
|
|||||
|
|
|
Here is the stock with buy rank and strong momentum characteristics for investors to consider today, June 4th:
BioCryst Pharmaceuticals BCRX: This company which is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its next year earnings increasing 83.3% over the last 60 days.
BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote
BioCryst Pharmaceuticals’ shares gained 39% over the last three month compared with the S&P 500’s gain of 2.2%. The company possesses a Momentum Score of B.
BioCryst Pharmaceuticals, Inc. price | BioCryst Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| 13 hours | |
| Jun-04 | |
| Jun-04 | |
| Jun-04 | |
| Jun-03 | |
| Jun-02 | |
| May-30 | |
| May-28 | |
| May-27 | |
| May-26 | |
| May-16 | |
| May-15 | |
| May-14 | |
| May-09 | |
| May-09 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite